Back to Oncology
Oncologyv1999Evidence-Based

Gail Model for Breast Cancer Risk

Estimates risk for breast cancer based on demographic and clinical data. The Gail Model calculates a woman's absolute risk of developing invasive breast cancer over the next 5 years and up to age 90 (lifetime risk) using personal medical and reproductive history and family history of breast cancer among first-degree relatives.

Clinical Input Parameters

years
Range: 35 — 85 years
years
years
Clinical Assessment
Awaiting Parameters
five year risk
—percentage
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Gail Model for Breast Cancer Risk is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Complex statistical model using logistic regression with race-specific coefficients for age, age at menarche, age at first live birth, number of first-degree relatives with breast cancer, number of breast biopsies, and presence of atypical hyperplasia.

Clinical Pearls & Practice Notes

  • Valid for women aged 35-85 years without personal history of breast cancer
  • Validated for White, African-American, Hispanic, and Asian/Pacific Islander women in the US
  • May underestimate risk in Black women with previous biopsies and Hispanic women born outside the US
  • Cannot be used for women with BRCA1/BRCA2 mutations or previous breast cancer
  • Does not include lifestyle factors (alcohol, physical activity, hormone therapy)
  • 5-year risk ≥1.67% is FDA threshold for chemoprevention consideration
  • Also calculates lifetime risk to age 90, but 5-year risk is primary clinical metric
  • Should be used as part of comprehensive breast cancer risk assessment

Evidence & Literature Citations

  1. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-86. doi: 10.1093/jnci/81.24.1879.
  2. Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999;91(18):1541-8. doi: 10.1093/jnci/91.18.1541.
  3. Matsuno RK, Costantino JP, Ziegler RG, et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst. 2011;103(12):951-61. doi: 10.1093/jnci/djr154.

Score Interpretation Ranges

Low Risk0 – 1.67 pts

Low risk for breast cancer

High Risk1.67 – 100 pts

High risk for breast cancer

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.